This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints, Permissions and Rights Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gibney, J. Articles by Sönksen, P. H. Search for Related Content PubMed PubMed Citation Articles by Gibney, J. Articles by Sönksen, P. H.

The Growth Hormone/Insulin-Like Growth Factor-I Axis in Exercise and Sport

Department of Endocrinology and Diabetes (J.G.), Adelaide and Meath Hospital, Tallaght, Dublin 24, Ireland; Department of Endocrinology and Diabetes (M.-L.H.), St. James’s Hospital, Dublin 8, Ireland; and Endocrinology and Metabolism Subdivision (P.H.S.), Developmental Origins of Adult Health and Disease Division, School of Medicine, University of Southampton, Southampton, United Kingdom

Correspondence: Address all correspondence and requests for reprints to: Peter Sönksen, East Wing Preshaw House, Preshaw, Upham, Hants SO32 1HP, United Kingdom. E-mail: PHSonksen{at}aol.com

The syndrome of adult GH deficiency and the effects of GH replacement therapy provide a useful model with which to study the effects of the GH/IGF-I axis on exercise physiology. Measures of exercise performance including maximal oxygen uptake and ventilatory threshold are impaired in adult GH deficiency and improved by GH replacement, probably through some combination of increased oxygen delivery to exercising muscle, increased fatty acid availability with glycogen sparing, increased muscle strength, improved body composition, and improved thermoregulation. In normal subjects, in addition to the long-term effects of GH/IGF-I status, there is evidence that the acute GH response to exercise is important in regulating substrate metabolism after exercise. Administration of supraphysiological doses of GH to athletes increases fatty acid availability and reduces oxidative protein loss, particularly during exercise, and increases lean body mass. Despite a lack of evidence that these metabolic effects translate to improved performance, GH abuse by athletes is widespread. Tests to detect GH abuse have been developed based on measurement in serum of 1) indirect markers of GH action, and 2) the relative proportions of the two major naturally occurring isoforms (20 and 22kDa) of GH. There is evidence that exercise performance and strength are improved by administration of GH and testosterone in combination to elderly subjects. The potential benefits of GH in these situations must be weighed against potential adverse effects.

This article has been cited by other articles:

				J. F. Husak and D. J. Irschick Steroid use and human performance: Lessons for integrative biologists Integr. Comp. Biol., October 1, 2009; 49(4): 354 - 364. [Abstract] [Full Text] [PDF]

				S. D. McCormick Evolution of the hormonal control of animal performance: Insights from the seaward migration of salmon Integr. Comp. Biol., October 1, 2009; 49(4): 408 - 422. [Abstract] [Full Text] [PDF]

				I. de Glisezinski, D. Larrouy, M. Bajzova, K. Koppo, J. Polak, M. Berlan, J. Bulow, D. Langin, M. A. Marques, F. Crampes, et al. Adrenaline but not noradrenaline is a determinant of exercise-induced lipid mobilization in human subcutaneous adipose tissue J. Physiol., July 1, 2009; 587(13): 3393 - 3404. [Abstract] [Full Text] [PDF]

				L. Di Luigi, A. E Rigamonti, F. Agosti, M. Mencarelli, P. Sgro, N. Marazzi, S. G Cella, E. E Muller, and A. Sartorio Combined evaluation of resting IGF1, N-terminal propeptide of type III procollagen and C-terminal cross-linked telopeptide of type I collagen levels might be useful for detecting inappropriate GH administration in female athletes Eur. J. Endocrinol., May 1, 2009; 160(5): 753 - 758. [Abstract] [Full Text] [PDF]

				G. Fanciulli, A. Delitala, and G. Delitala Growth hormone, menopause and ageing: no definite evidence for 'rejuvenation' with growth hormone Hum. Reprod. Update, May 1, 2009; 15(3): 341 - 358. [Abstract] [Full Text] [PDF]

				N. Moller and J. O. L. Jorgensen Effects of Growth Hormone on Glucose, Lipid, and Protein Metabolism in Human Subjects Endocr. Rev., April 1, 2009; 30(2): 152 - 177. [Abstract] [Full Text] [PDF]

				W. M. Widdowson and J. Gibney The Effect of Growth Hormone Replacement on Exercise Capacity in Patients with GH Deficiency: A Metaanalysis J. Clin. Endocrinol. Metab., November 1, 2008; 93(11): 4413 - 4417. [Abstract] [Full Text] [PDF]

				K. R. Short, N. Moller, M. L. Bigelow, J. Coenen-Schimke, and K. S. Nair Enhancement of Muscle Mitochondrial Function by Growth Hormone J. Clin. Endocrinol. Metab., February 1, 2008; 93(2): 597 - 604. [Abstract] [Full Text] [PDF]